şizofrenik bozuklukta cinsel işlev bozuklukları - Çukurova Üniversitesi

82. Tran PV, Hamilton SH, Kuntz AJ, Potvin JH, Anderson SW, Beasley CJr and Tollefson GD.
Double-blind comparison of olanzapin versus risperidone in the treatment of schizophrenia and other
psychotik disorders. Journal of Clinical Psychopharmacology, 1997; 17:407-418.
83. Bobes J, Garc A, Portilla MP, Rejas J Hern NG, Garcia M, Rico VF and Porras A. Frequency
of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with
risperidone, olanzapine, quetiapine or holoperidol, The results of the EIRE study. Journal of Sex and
Marital Therapy, 2003; 29:125-147.
84. Turrone P, Kapur S, Seeman MV and Flint AJ. Elevation of prolactin levels by atypical
antipsychotics. American Journal of Psychiatry, 2002; 159:133-135.
85. Peacock L, Solgard T, Lublin H and Gerlach J. Clozapine versus typical antipsychotics: Effects
and side effects. Neuropsychopharmacology. 1994;10:223-354.
86. Aizenberg D, Modai I, Landa A, Gil-Ad I and Weizman A. Comparison of sexual dysfonction in
male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine.
Journal of Clinical Psychiatry, 2001; 62:541-544,
87. Hummer M, Kemmler G, Kurz M, Kurzthaler I, Oberbauer H and Fleishhacker WW. Sexual
disturbancesduring clozapine and haloperidol treatment for schizophrenia. American Journal of
Psychiatry, 1999; 156(4):631-633.
88. Mullen B, Brar JS, Vagnucci AH and Gangulu R. Frequency of sexual dysfunctions in patients
with schizophrenia on haloperidol, clozapine or risperidone. Schizophrenia Research, 2001; 48:155-
158.
89. Compton MT and Miller AH. Priapism associated with conventional and atypical antipsychotic
madications: A review. Journal of Clinical Psychiatry, 2001; 62(5):362-366.
90. Novartis Pharamceuticals. “Clozaril (Clozapine) Tablets” Product monograph. East Hanover NJ:
2002; Novartis.
91. Kleinberg DL, Davis JM, de Coster R, Van Baelen B and Brecher M. Proloktin levels and advers
events in patients treated with risperidone. Journal of Clinical Psychopharmacology, 1999; 19:57-61.
92. Bobes J, Gutierrex M, Gilbert J, Gonzalez MP and Herraiz ML. Quality of life and disability in
chronic schizophrenics treated with depot neuroleptics. Actas Espanolas de Psiquiatria, 1999;
27(4):229-234.
93. Conley RR and Mahmoud R. Arandomized double-blind study of risperidone and olanzapine in the
treatment of schizophrenia or schizoaffective disorder. American Journal of Psichiatry, 2001;
158(5):765-774.
94. Mabini R, Wergowske G and Baker FM. Galactorrhea and gynecomastia in a hypothyroid male
being treated with risperidone. Psychiatric Services, 2000; 51:983-985.
95. Kaneda Y. Risperidone-induced ejaculatory dysfunction: A case report. European Psychiatry, 2001;
16(2):134-135.
96. Nicolson R, and McCurley R. Risperidone-associated priapism. [Letter]. Journal of Clinical
Psychopharmacology, 1997; 17(2):133-134.
57